Teva Names Former Sandoz CEO Francis To Replace Schultz Within Weeks

Richard Francis Will Take Lead At Israeli Generics Giant From The Start Of 2023

 
• By David Wallace
  
Francis_Richard
Richard Francis will replace Kåre Schultz as president and CEO of Teva
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Leadership

More from Generics Bulletin